Information Provided By:
Fly News Breaks for January 27, 2020
EL
Jan 27, 2020 | 07:30 EDT
As previously reported, Oppenheimer analyst Rupesh Parikh downgraded Estee Lauder to Perform from Outperform with a price target of $210, down from $230, and removed the stock as a Top Pick. Following recent developments in China with the coronavirus coupled with the premium valuation at which shares trade, the analyst no longer views the risk/reward as attractive from current levels. Although difficult to measure the precise impact and the length at which the coronavirus-related challenges could persist within the Chinese economy, he now expects Estee Lauder's higher margin travel-retail segment to be adversely impacted at least in Q3 and potentially longer.
News For EL From the Last 2 Days
EL
Mar 28, 2024 | 12:00 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
EL
Mar 28, 2024 | 05:51 EDT
BofA upgraded Estee Lauder to Buy from Neutral with a price target of $170, up from $160. The company currently has a range of initiatives to recovery profitability, sharpen product efficiency, and achieve more balance across channels and geographies, the analyst tells investors in a research note. The firm expects market share growth and operating leverage as Estee reduces its reliance on China and travel retail. It believes the company's earnings have bottomed.